| 12 Avril 2013
 Endometriosis is a common, and often painful, gynecological disease  where tissue normally found inside the uterus, grows elsewhere in the  body.   According to the World Health Organization this  estrogen-dependent disease affects roughly 14% of women of childbearing  age.  The National Institutes of Health (NIH) estimates that more than  5.5 million women in North America have endometriosis, and if left  untreated can cause infertility in up to 40% of women who are unable to  conceive.   Prior research shows an increased risk of several cancers, including  ovarian cancer, in women with endometriosis.  Some studies have found a  protective effect against ovarian cancer with surgical interventions,  such as hysterectomy or tubal ligation.  Lead author, Dr. Anna-Sofia  Melin from the Karolinska Institute and Karolinska University Hospital  in Stockholm, Sweden explains, “Patients with endometriosis are  typically treated with hormones, or in more severe cases, with surgery.   We wanted to expand understanding of ovarian cancer risk in women with  endometriosis who had some type of surgery or hormone therapy.”  Using  the National Swedish Patient Register, the team identified women  diagnosed with endometriosis between 1969 and 2007.    The National  Swedish Cancer Register was then used to link women who were diagnosed  with epithelial ovarian cancer at least one year following a diagnosis  of endometriosis.    Information on hormonal and surgical treatments was  taken from medical records of the 220 women with endometriosis and  ovarian cancer (cases) and 416 women with endometriosis only (controls).   Findings indicate a significant association between the surgical  removal of an ovary (oophorectomy) and ovarian cancer risk.  A  significant link between ovarian cancer risk and radical removal of all  visible endometriosis was also found.  “Our study suggests that surgical  removal of an ovary and removal of visible endometriosis protects women  from developing ovarian cancer at a later point,” concludes Dr. Melin.   “For women with endometriosis, the role of hormonal treatment and  future ovarian cancer risk remains unclear and further investigation is  warranted.”  A novel study shows women who undergo surgical treatment for  endometriosis have a lower risk of developing ovarian cancer.  According  to results published in  Acta Obstetricia et Gynecologica Scandinavica,  a journal of the Nordic Federation of Societies of Obstetrics and  Gynecology, hormonal treatments for endometriosis did not lower ovarian  cancer risk.
A novel study shows women who undergo surgical treatment for  endometriosis have a lower risk of developing ovarian cancer.  According  to results published in  Acta Obstetricia et Gynecologica Scandinavica,  a journal of the Nordic Federation of Societies of Obstetrics and  Gynecology, hormonal treatments for endometriosis did not lower ovarian  cancer risk. 









